| Literature DB >> 19442265 |
Gunnel Sandqvist1, Pia Malcus Johnsson, Anna-Lena Sturesson, Magnus Tägil, Pierre Geborek.
Abstract
BACKGROUND: Rheumatic diseases commonly affect joints and other structures in the hand. Surgery is a traditional way to treat hand problems in inflammatory rheumatic diseases with the purposes of pain relief, restore function and prevent progression. There are numerous measures to choose from, and a combination of outcome measures is recommended. This study evaluated if instruments commonly used in rheumatologic clinical practice are suitable to measure outcome of hand surgery and to identify time points relevant for follow-up.Entities:
Mesh:
Year: 2009 PMID: 19442265 PMCID: PMC2691396 DOI: 10.1186/1471-2474-10-50
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Clinical characteristics and type of surgery in the patients
| Median (range) | |
| No. of male/female | 7/24 |
| Age (years) | 56 (28 – 81) |
| Disease duration (years) | 15 (1–32) |
| HAQ | 1.25 (0.38 – 2.38) |
| RA | 29 |
| Psoriatic arthritis | 2 |
| DMARD and TNF-blockers | 5 |
| DMARD | 21 |
| NSAID/none | 5 |
| Joint surgery | |
| MCP implant arthroplasty | 6 |
| Arthrodesis in the wrist | 4 |
| Arthrodesis in fingers | 1 |
| Soft tissue surgery | |
| Tenosynovectomy | 6 |
| Carpal tunnel release | 1 |
| Centralization of extensor tendons | 3 |
| Two procedures in one handx | 10 |
x mostly a combination of arthrodesis in the wrist and arthroplasty in the CMC 1 joint
Performance of hand function, symptoms and activities, at baseline and at 3, 6 and 12 month follow-up
| Baseline | 3-month follow-up | 6-month follow-up | ||
| Grippit (N) | 57 (2–254) | 54 (0 – 317) | ||
| VAS general pain (0–100) | 50 (4–100) | |||
| SOFI | 3 (0–7) | 3 (0–5) | 3 (0 – 6) | |
| GAT | 31 (13–183) | |||
| DASH, symptoms (0 – 100) | 50 (25 – 83.3) | |||
| Activity and participation | ||||
| DASH, activities (0 – 100) | 51.2 (11.9 – 83.3) | 42.3 (3.6 – 82.1) | ||
| COPM (0 – 10) | ||||
| Performance of activities | 3.8 (1 – 7.3) | |||
| Satisfaction with | 2 (1 – 6.7) |
* = p < 0.05, ** = p < 0.01, *** = p < 0.001
Bold figures represent significant differences between baseline and the different follow-up points
Figure 1SMR for the different instruments at follow up 3, 6, and 12 month.